E. Jon Popke, Ph.D., M.B.A. Experienced drug safety professional and early-stage healthcare investor; over 20 years of proven leadership in a variety of drug development settings; currently serving as Executive Director, Toxicology with Regeneron Pharmaceuticals.I received my Ph.D. from the Uniformed Services University of the Health Sciences, Bethesda, MD, and my M.B.A from the University of Michigan, Ross School of Business. Over the course of my career, I have held scientific and drug development positions of increasing responsibility with the U.S. Food and Drug Administration, Wyeth Research, MPI Research and Regeneron Pharmaceuticals. I served as Vice President of the Behavioral Toxicology Society from 2004-2005 and as President from 2005-2006. I served as an ad hoc member of the Executive Committee of the African Society for Toxicological Sciences from 2004 through 2006 and sat on the Board of Directors for the Michigan Society for Medical Research from 2008-2010. I am an active investor in early-stage health care companies and provide mentoring in support of startup entrepreneurs in Africa.Specialties: Drug Development • Scientific and Professional Leadership • Due-Diligence and Early-Stage Investing • Outsourcing and Vendor Management • Regulatory Compliance and Submission • Science, Business and Personnel Strategy